Acies Bio

Ljubljana, Slovenia Founded: 2006 • Age: 20 yrs
Provider of drug discovery and development services to pharmaceutical, biotech, and food industries

About Acies Bio

Acies Bio is a Healthcare company based in Ljubljana (Slovenia) founded in 2006. Provider of drug discovery and development services to pharmaceutical, biotech, and food industries. Acies Bio offers products and services including Strain Development, Fermentation Process Development, and DSP Development. Its focus areas include Biopharma Outsourcing, CRO, Drug Discovery and Medicinal Chemistry. Its legal entity is ACIES BIO D.O.O.

Company details

Acies Bio was founded in 2006 in Ljubljana, Slovenia, where operations are based. Services in drug discovery and development are offered to clients in the pharmaceutical, biotechnology, and food sectors. Focus is placed on innovative solutions for research and production processes. Expertise is applied across microbial engineering and bioprocess optimization to support industry needs in Europe and beyond.

  • Headquarters Ljubljana, Slovenia
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website aciesbio.com
  • Social LinkedIn
  • Legal Name Acies Bio D.O.O.
Key Metrics
  • Latest Funding Round
    $101.82K (USD), Grant

    Sep 2022

  • Investors
    ADM

    & 2 more

Products & Services of Acies Bio

Acies Bio offers a comprehensive portfolio of products and services, including Strain Development, Fermentation Process Development, and DSP Development.

Strain Development
Biotech Service

Develops microbial strains using evolution and synthetic biology methods

Fermentation Process Development
Process Engineering

Designs industrial-scale fermentation processes for biotechnology applications

DSP Development
Processing Service

Handles fermentation broth processing to final product stages

Funding Insights of Acies Bio

  • Total Rounds 9
  • Last Round Grant β€” $101,820
  • First Round $56,535

    (Feb 2015)

  • Investors Count 3

All 9 funding rounds of Acies Bio with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Sep 2022$101,820Grant––
Oct 2021Seed–ADM
–
May 2018$188,607Grant––
Oct 2017$2.07MGrant––
Sep 2017$87,766Grant––
Jan 2017$588,661Grant––
Nov 2015$1.96MGrant––
May 2015$54,939Grant––
Feb 2015$56,535Grant––
Valuation history

3 investors in total: 3 institutional.

Investors in Acies Bio

Acies Bio has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include ADM, European Union and EIC Fund.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Government agency and accelerator focusing on innovative startups and SMEs
eicfund.euBrussels, Belgium
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
ADM is recognized as a leader in human and animal nutrition solutions.
1902adm.comChicago, United States
Premium access

Investor details for Acies Bio

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Acies Bio

3 dated milestones of Acies Bio across 16 years, from founding to its latest funding, stage changes and deals.

  1. Founded Acies Bio is founded.
  2. Funding First funding round of $57K.
  3. Funding Latest funding round, Grant, of $102K.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Acies Bio

Premium access

Complete news archive for Acies Bio

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Acies Bio

Acies Bio was founded in 2006 and raised its 1st funding round 9 years after it was founded.

Acies Bio is headquartered in Ljubljana, Slovenia.

Acies Bio was founded in 2006 in Ljubljana, Slovenia, where operations are based. Services in drug discovery and development are offered to clients in the pharmaceutical, biotechnology, and food sectors. Focus is placed on innovative solutions for research and production processes. Expertise is applied across microbial engineering and bioprocess optimization to support industry needs in Europe and beyond.

Acies Bio offers Strain Development, Fermentation Process Development, and DSP Development.

Acies Bio has 3 investors. Key investors include ADM, European Union, and EIC Fund.

Acies Bio operates through Acies Bio D.O.O..

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available